Review




Structured Review

Stayhealthy Inc waist-mounted accelerometer rt3
Waist Mounted Accelerometer Rt3, supplied by Stayhealthy Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt3+accelerometers/3+dimensional+accelerometer+rt3/pmc03909967-58-8-2
Average 90 stars, based on 1 article reviews
waist-mounted accelerometer rt3 - by Bioz Stars, 2026-11
90/100 stars

Images

Related Articles

Activity Assay:

Article Title: Association of 1,25-Dihydroxyvitamin D Levels With Physical Performance and Thigh Muscle Cross-sectional Area in Chronic Kidney Disease Stage 3 and 4
Article Snippet: .. 27 Physical Activity Level Physical activity levels were measured using a 3-dimensional accelerometer (RT3, Stayhealthy Inc., Monrovia, CA). ..

Article Title: Association of 1,25-Dihydroxyvitamin D Levels With Physical Performance and Thigh Muscle Cross-sectional Area in Chronic Kidney Disease Stage 3 and 4
Article Snippet: .. Physical activity levels were measured using a 3-dimensional accelerometer (RT3, Stayhealthy Inc., Monrovia, CA). ..

Article Title: Magnitude of daily energy deficit predicts frequency but not severity of menstrual disturbances associated with exercise and caloric restriction
Article Snippet: .. Subjects wore a research accelerometer (RT3; Stayhealthy, Monrovia, CA) for 24 h/day (except during training bouts, swimming, and bathing) during the first 7 days of the follicular phase of the baseline cycle for the assessment of nonexercise physical activity (PA) caloric expenditure ( 21 , 31 ). ..

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease
Article Snippet: .. During the treatment period, patients were not allowed to use beta‐blockers, cromolyns, antileukotrienes, inhaled LABAs, long‐acting anticholinergics, or any other investigational drug Outcomes Primary : difference in daily physical activity measured in vector magnitude units (VMUs) by the triaxial Stayhealthy RT3 accelerometer at the end of the treatment period Secondary : the difference in physical activity measured in VMUs by the triaxial Stayhealthy RT3 accelerometer at 1 month and 2 month treatment period, trough (10±3 minutes predose) FEV 1 , peak FEV 1 as measured by the maximum post‐bronchodilator value obtained within 2 hours of testing on study days (30±5, 60±10, and 120±10 minutes), trough and peak SVC measured at the same time as the FEV 1 on each study day, trough and peak inspiratory capacity (IC) measured at the same time as the FEV 1 on each study day, trough and peak forced inspiratory volume in one second (FIV 1 ) measured at the same time as the FEV 1 on each study day, distance covered in the six‐minute walk distance (6MWD), modified Borg Dyspnoea Scale, quality of life as measured by the Chronic Respiratory Questionnaire (CRQ), use of salbutamol (rescue medication) during the treatment period, time point at which a 20% improvement from baseline in physical activity was achieved, physician’s Global Assessment Notes Funding : Boehringer Ingelheim Study number : Boehringer Ingelheim 205.269, ClinicalTrials.gov NCT00144326 Definitions : an exacerbation of COPD was defined as a complex of respiratory symptoms (two or more) COPD‐related (increased or new onset) with a duration of at least three days. ..

Article Title: Correlates of Physical Functioning and Performance Across the Spectrum of Kidney Function.
Article Snippet: .. Physical activity was measured using a three-dimensional accelerometer (RT3, Stayhealthy Inc., Monrovia, CA). ..

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease
Article Snippet: .. Outcomes , Primary : difference in daily physical activity measured in vector magnitude units (VMUs) by the triaxial Stayhealthy RT3 accelerometer at the end of the treatment period Secondary : the difference in physical activity measured in VMUs by the triaxial Stayhealthy RT3 accelerometer at 1 month and 2 month treatment period, trough (10±3 minutes predose) FEV 1 , peak FEV 1 as measured by the maximum post‐bronchodilator value obtained within 2 hours of testing on study days (30±5, 60±10, and 120±10 minutes), trough and peak SVC measured at the same time as the FEV 1 on each study day, trough and peak inspiratory capacity (IC) measured at the same time as the FEV 1 on each study day, trough and peak forced inspiratory volume in one second (FIV 1 ) measured at the same time as the FEV 1 on each study day, distance covered in the six‐minute walk distance (6MWD), modified Borg Dyspnoea Scale, quality of life as measured by the Chronic Respiratory Questionnaire (CRQ), use of salbutamol (rescue medication) during the treatment period, time point at which a 20% improvement from baseline in physical activity was achieved, physician’s Global Assessment , . .. Notes , Funding : Boehringer Ingelheim Study number : Boehringer Ingelheim 205.269, ClinicalTrials.gov NCT00144326 Definitions : an exacerbation of COPD was defined as a complex of respiratory symptoms (two or more) COPD‐related (increased or new onset) with a duration of at least three days. COPD‐related respiratory symptoms consisted of cough, wheeze, dyspnoea, shortness of breath, chest tightness, or increase in production and/or purulence in sputum. These symptoms must have been accompanied with antibiotic treatment and/or systemic corticoids (oral, intramuscular or endovenous) or with a significant change in respiratory medication prescribed , .

Article Title: Less-than-expected weight loss in normal-weight women undergoing caloric restriction and exercise is accompanied by preservation of fat-free mass and metabolic adaptations.
Article Snippet: .. The thermic effect was defined as 10% of caloric intake.34 Exercise expenditure was obtained from heart rate monitors,35 and non-exercise activity was assessed by triaxial accelerometry (RT3, Stayhealthy).36,37 Weight loss as well as changes in fat and fat-free mass were predicted using the National Institute of Health Body Weight Planner,38 which utilizes mathematical modeling of human metabolism to simulate adaptations in energy expenditure during weight loss. ..

Modification:

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease
Article Snippet: .. During the treatment period, patients were not allowed to use beta‐blockers, cromolyns, antileukotrienes, inhaled LABAs, long‐acting anticholinergics, or any other investigational drug Outcomes Primary : difference in daily physical activity measured in vector magnitude units (VMUs) by the triaxial Stayhealthy RT3 accelerometer at the end of the treatment period Secondary : the difference in physical activity measured in VMUs by the triaxial Stayhealthy RT3 accelerometer at 1 month and 2 month treatment period, trough (10±3 minutes predose) FEV 1 , peak FEV 1 as measured by the maximum post‐bronchodilator value obtained within 2 hours of testing on study days (30±5, 60±10, and 120±10 minutes), trough and peak SVC measured at the same time as the FEV 1 on each study day, trough and peak inspiratory capacity (IC) measured at the same time as the FEV 1 on each study day, trough and peak forced inspiratory volume in one second (FIV 1 ) measured at the same time as the FEV 1 on each study day, distance covered in the six‐minute walk distance (6MWD), modified Borg Dyspnoea Scale, quality of life as measured by the Chronic Respiratory Questionnaire (CRQ), use of salbutamol (rescue medication) during the treatment period, time point at which a 20% improvement from baseline in physical activity was achieved, physician’s Global Assessment Notes Funding : Boehringer Ingelheim Study number : Boehringer Ingelheim 205.269, ClinicalTrials.gov NCT00144326 Definitions : an exacerbation of COPD was defined as a complex of respiratory symptoms (two or more) COPD‐related (increased or new onset) with a duration of at least three days. ..

Article Title: Tiotropium versus placebo for chronic obstructive pulmonary disease
Article Snippet: .. Outcomes , Primary : difference in daily physical activity measured in vector magnitude units (VMUs) by the triaxial Stayhealthy RT3 accelerometer at the end of the treatment period Secondary : the difference in physical activity measured in VMUs by the triaxial Stayhealthy RT3 accelerometer at 1 month and 2 month treatment period, trough (10±3 minutes predose) FEV 1 , peak FEV 1 as measured by the maximum post‐bronchodilator value obtained within 2 hours of testing on study days (30±5, 60±10, and 120±10 minutes), trough and peak SVC measured at the same time as the FEV 1 on each study day, trough and peak inspiratory capacity (IC) measured at the same time as the FEV 1 on each study day, trough and peak forced inspiratory volume in one second (FIV 1 ) measured at the same time as the FEV 1 on each study day, distance covered in the six‐minute walk distance (6MWD), modified Borg Dyspnoea Scale, quality of life as measured by the Chronic Respiratory Questionnaire (CRQ), use of salbutamol (rescue medication) during the treatment period, time point at which a 20% improvement from baseline in physical activity was achieved, physician’s Global Assessment , . .. Notes , Funding : Boehringer Ingelheim Study number : Boehringer Ingelheim 205.269, ClinicalTrials.gov NCT00144326 Definitions : an exacerbation of COPD was defined as a complex of respiratory symptoms (two or more) COPD‐related (increased or new onset) with a duration of at least three days. COPD‐related respiratory symptoms consisted of cough, wheeze, dyspnoea, shortness of breath, chest tightness, or increase in production and/or purulence in sputum. These symptoms must have been accompanied with antibiotic treatment and/or systemic corticoids (oral, intramuscular or endovenous) or with a significant change in respiratory medication prescribed , .

other:

Article Title: Does Physical Activity Increase After Total Hip or Knee Arthroplasty for Osteoarthritis? A Systematic Review.
Article Snippet: 171 A range of activity monitoring devices were used across studies, including uni-axial2, 12, 22 172 39(e.g. activPAL), biaxial14 (e.g. Actigraph GT1M) and tri-axial accelerometers21 (e.g. 173 StayHealthy RT3).



Similar Products

90
Stayhealthy Inc rt3 accelerometer
Characteristics of devices reported in the literature.
Rt3 Accelerometer, supplied by Stayhealthy Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt3+accelerometers/rt3+accelerometer/pmc12004692-28-8-10
Average 90 stars, based on 1 article reviews
rt3 accelerometer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Stayhealthy Inc rt3 accelerometer stayhealthy
A summary of the three application areas of digital health in COPD
Rt3 Accelerometer Stayhealthy, supplied by Stayhealthy Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt3+accelerometers/stayhealthy+rt3/pmc11823091-27-20-22
Average 90 stars, based on 1 article reviews
rt3 accelerometer stayhealthy - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Stayhealthy Inc rt3 accelerometer stayhealthy, inc., monrovia, ca
Study outcomes as reported in the included studies.
Rt3 Accelerometer Stayhealthy, Inc., Monrovia, Ca, supplied by Stayhealthy Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt3+accelerometers/rt3+accelerometer+stayhealthy++inc+++monrovia++ca/pmc11817475-44-5-7
Average 90 stars, based on 1 article reviews
rt3 accelerometer stayhealthy, inc., monrovia, ca - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
ActiGraph llc rt3 accelerometers
Study outcomes as reported in the included studies.
Rt3 Accelerometers, supplied by ActiGraph llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt3+accelerometers/rt3/pm37909080-776-7-3
Average 90 stars, based on 1 article reviews
rt3 accelerometers - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Stayhealthy Inc rt3 triaxial accelerometers
Study outcomes as reported in the included studies.
Rt3 Triaxial Accelerometers, supplied by Stayhealthy Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt3+accelerometers/rt3+accelerometer/pm37638974-38-31-34
Average 90 stars, based on 1 article reviews
rt3 triaxial accelerometers - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Stayhealthy Inc waist-mounted rt3 triaxial accelerometer
Study outcomes as reported in the included studies.
Waist Mounted Rt3 Triaxial Accelerometer, supplied by Stayhealthy Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt3+accelerometers/waist+mounted+rt3+triaxial+accelerometer/pm37226675-52-6-10
Average 90 stars, based on 1 article reviews
waist-mounted rt3 triaxial accelerometer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Skidmore Medical Limited triaxial accelerometer rt3
Study outcomes as reported in the included studies.
Triaxial Accelerometer Rt3, supplied by Skidmore Medical Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rt3+accelerometers/triaxial+accelerometer+rt3/pmc10079053__pone__0284164__s008-26-13-18
Average 90 stars, based on 1 article reviews
triaxial accelerometer rt3 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Characteristics of devices reported in the literature.

Journal: Contemporary clinical trials

Article Title: Wearable activity monitors in oncology trials: Current use of an emerging technology

doi: 10.1016/j.cct.2017.11.002

Figure Lengend Snippet: Characteristics of devices reported in the literature.

Article Snippet: Guinan [ ] , Breast, post-treatment , (1) RT3 accelerometer (Stayhealthy Inc) , (1) Hip , (1) Physical activity (METs, time sedentary, intensity).

Techniques: Activity Assay, Adhesive

Comparison of wearable activity monitors used in oncology triales.

Journal: Contemporary clinical trials

Article Title: Wearable activity monitors in oncology trials: Current use of an emerging technology

doi: 10.1016/j.cct.2017.11.002

Figure Lengend Snippet: Comparison of wearable activity monitors used in oncology triales.

Article Snippet: Guinan [ ] , Breast, post-treatment , (1) RT3 accelerometer (Stayhealthy Inc) , (1) Hip , (1) Physical activity (METs, time sedentary, intensity).

Techniques: Comparison, Activity Assay, Software, Battery, Derivative Assay, Clinical Proteomics

A summary of the three application areas of digital health in COPD

Journal: BMC Medical Informatics and Decision Making

Article Title: Applications of digital health technologies and artificial intelligence algorithms in COPD: systematic review

doi: 10.1186/s12911-025-02870-7

Figure Lengend Snippet: A summary of the three application areas of digital health in COPD

Article Snippet: A. Dias et al. [ ] , 58 individuals COPD undergoing LTOT(35 males, 23 females) , GT1M accelerometer (Actigraph LLC) RT3 accelerometer (Stayhealthy) , Physical activity (PA) , 17 features SD2, SK2, LC2, MC3, AC242, AC243, MF2, MF3, E2, E3, LCF2, LCF3, HLC3, HACC2, HACC3, HLCC2, HLCC3 , logarithmic regression (LOG) support vector machines (SVM) , feed-forward neural network (NN) with 50 neurons in the hidden layer , specificity = 85%, sensitivity = 100%, AUC = 90%.

Techniques: Biomarker Discovery, Standard Deviation, Activity Assay, Plasmid Preparation, Clinical Proteomics, Software, Extraction, Control

Study outcomes as reported in the included studies.

Journal: Healthcare

Article Title: A Systematic Review of Community-Based Exercise Interventions for Adults with Intellectual Disabilities

doi: 10.3390/healthcare13030299

Figure Lengend Snippet: Study outcomes as reported in the included studies.

Article Snippet: Method of PA measurement , RT3 accelerometer (Stayhealthy, Inc., Monrovia, CA, USA) Pedometer (Omron, Walking Style Pro, HJ-720ITE2) Logbook data , Actigraph GT3X accelerometer (Manufacturing Technology Inc., Crestview, FL, USA) Omron Walking Style III pedometer (Omron Healthcare Inc., Hoffman Estates, IL, USA) , Actigraph GT1X accelerometer (Pensacola, FL, USA) , Fitbit Flex2 , Actigraph GT3X+ accelerometers (Manufacturing Technology Inc.) International Physical Activity Questionnaire-Short (IPAQ-S).

Techniques: Activity Assay

Physical activity outcome measures and results in the included studies.

Journal: Healthcare

Article Title: A Systematic Review of Community-Based Exercise Interventions for Adults with Intellectual Disabilities

doi: 10.3390/healthcare13030299

Figure Lengend Snippet: Physical activity outcome measures and results in the included studies.

Article Snippet: Method of PA measurement , RT3 accelerometer (Stayhealthy, Inc., Monrovia, CA, USA) Pedometer (Omron, Walking Style Pro, HJ-720ITE2) Logbook data , Actigraph GT3X accelerometer (Manufacturing Technology Inc., Crestview, FL, USA) Omron Walking Style III pedometer (Omron Healthcare Inc., Hoffman Estates, IL, USA) , Actigraph GT1X accelerometer (Pensacola, FL, USA) , Fitbit Flex2 , Actigraph GT3X+ accelerometers (Manufacturing Technology Inc.) International Physical Activity Questionnaire-Short (IPAQ-S).

Techniques: Activity Assay, Control, Comparison